A new COVID-19, BA.3.2 variant, is spreading across at least 25 U.S. states, researchers say, with early evidence suggesting it may evade protection from current vaccines designed for earlier strains.
Variant Detected Across Multiple States and Samples
The BA.3.2 variant has been identified in clinical and environmental samples across the United States, signaling wider circulation than initially detected. Researchers found the strain in nasal swabs from four international travelers and five patients in four states.
In addition, scientists detected the variant in three airplane wastewater samples and 132 wastewater samples collected across more than 20 states. Public health experts say wastewater surveillance often reveals broader spread before clinical cases rise.
“Wastewater data suggests the variant is already more widespread than confirmed cases indicate,” researchers noted in a federal report.
The Centers for Disease Control and Prevention continues monitoring the variant as part of its ongoing genomic surveillance efforts. Officials have not yet released a full breakdown of affected states.
Scientists Warn of Potential Vaccine Evasion
Researchers say BA.3.2 variant may pose new challenges because of its genetic differences from currently dominant strains. The variant is a descendant of omicron but is “genetically distinct” from the JN.1 lineage, which has circulated widely in the U.S. since early 2024.
Current COVID-19 vaccines primarily target JN.1 subvariants, raising concerns that their effectiveness could be reduced against BA.3.2.
“This level of genetic divergence could impact how well existing vaccines perform,” scientists wrote in the CDC’s Morbidity and Mortality Weekly Report.
Health experts emphasize that more data is needed to determine the variant’s transmissibility, severity, and immune escape potential. However, they say the findings may warrant updates to vaccine formulations if the strain continues to spread.
Global Spread and Evolution Raise Concerns
BA.3.2 variant was first detected in South Africa in 2024 and later identified in the United States in June 2025 in a traveler arriving from the Netherlands. The variant began increasing rapidly in September 2025 and has since been reported in 23 countries.
Its evolution mirrors earlier variants such as BA.2.86, which emerged in 2024 and eventually led to the JN.1 strain that dominated infections that year. Scientists say such evolutionary patterns highlight the virus’s ability to adapt and persist.
Public health officials are urging continued vigilance, including testing and monitoring, as researchers work to better understand the variant’s impact.
“We are still learning about BA.3.2, but early detection gives us time to respond,” a public health official said.
Authorities have not announced new restrictions but say guidance could change as more evidence becomes available.
